While some studies do not consider this biomarker to be sufficiently sensitive for diagnosing primary and malignant breast tumors [14, 29], others have demonstrated its diagnostic value either alone [30, 31] or in combination with other biomarkers such as AFP, CA-153, and CEA [32, 33]. This evidence concerns the gene MUC1 and breast cancer.